本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Ascendis Pharma A/S

247.69
+7.923.30%
盤後247.690.00000.00%19:57 EDT
成交量:126.01萬
成交額:3.09億
市值:163.95億
市盈率:19.11
高:249.01
開:239.70
低:237.23
收:239.77
52周最高:282.15
52周最低:186.05
股本:6,618.99萬
流通股本:6,553.95萬
量比:1.31
換手率:1.92%
股息:- -
股息率:- -
每股收益(TTM):12.96
每股收益(LYR):-4.4176
淨資產收益率:118.78%
總資產收益率:9.58%
市淨率:9.96
市盈率(LYR):-56.07

資料載入中...

2023/12/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/12/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/12/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/12/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/09/28

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/09/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/09/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/09/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/09/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/09/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/09/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/09/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/09/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/05/10

關聯方擬減持公告

144 - Report of proposed sale of securities
2023/05/05

關聯方擬減持公告

144 - Report of proposed sale of securities
2023/04/10

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/28

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2023/02/16

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/02/14

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals